[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349697-105":59,"doc-detail-349697-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","oncogenic-and-immunological-roles-of-nsun2-in-triple-negative-breast-cancer","Oncogenic and immunological roles of NSUN2 in triple negative breast cancer","","Immunotherapy can induce clinical remissions in many solid tumors, yet immunotherapeutic monotherapy remains insufficient for triple-negative breast cancer (TNBC). NSUN2 acts as a proto-oncogene across cancers, but its influence on the TNBC immune microenvironment and links to treatment sensitivity require clarification. This study reports high NSUN2 expression in pan-cancer, with elevated levels associated with worse TNBC prognosis. NSUN2 correlates with immune infiltration and checkpoint molecule expression, and modulates drug sensitivity; NSUN2 depletion suppresses TNBC proliferation and migration.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/oncogenic-and-immunological-roles-of-nsun2-in-triple-negative-breast-cancer/349697/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/oncogenic-and-immunological-roles-of-nsun2-in-triple-negative-breast-cancer/349697.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is TNBC immunotherapy monotherapy still insufficient?","Question",{"text":112,"@type":113},"Despite clinical remissions in many solid tumors, monotherapy efficacy in TNBC is not very satisfactory, indicating a need for improved strategies to enhance antitumor immunity.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is NSUN2 related to TNBC prognosis and immune features?",{"text":117,"@type":113},"NSUN2 is highly expressed and higher levels correlate with poor prognosis in TNBC, and its expression positively associates with immune cell infiltration and immune checkpoint molecule expression.",{"name":119,"@type":110,"acceptedAnswer":120},"How does NSUN2 affect TNBC cell behavior and treatment sensitivity?",{"text":121,"@type":113},"Depleting NSUN2 significantly inhibits TNBC cell proliferation and migration, and upregulated NSUN2 is linked to reduced sensitivity to many chemotherapy drugs while showing increased sensitivity to some molecular-targeted agents.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349697,1790432794,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nOncogenic and immunological roles of NSUN2 in triple negative breast cancer  \nNing An1, Yi-Fan Zeng2, Zhuo-wanTian2, Jie Tian2, Ling-Feng Xu1, Ya-Long Yang3, Hong-Mei Zheng3, Jing-Wei Zhang2􀀍 & Yi-qing Xi1􀀍  \nImmunotherapy have led to clinical remissions in many solid tumors. However, the efficacy of immunotherapeutic monotherapy in triple-negative breast cancer (TNBC) is not very satisfactory. NSUN2 functions as a proto-oncogene in various cancers, promoting tumor cell proliferation, invasion, and metastasis. However, its role in modulating the tumor immune microenvironment, particularly inTNBC immunotherapy and its relationship with treatment sensitivity inTNBC remain to be further explored. In this study, we found that NSUN2 was highly expressed in pan-cancer, and elevated levels correlate with poor prognosis inTNBC. Furthermore, NSUN2 expression demonstrated a positive correlation with immune cell infiltration and the expression of immune checkpoint molecules. Upregulated NSUN2 expression lowers the sensitivity of many chemotherapy drugs, and higher the sensitivity of many molecular-targeted agents. Functionally, depleted NSUN2 inhibits the proliferation and migration ofTNBC cells significantly. Our study reveals the critical role of NSUN2 in regulating the immune microenvironment ofTNBC, provides a theoretical foundation for its potential as a novel immunotherapy target, addresses the knowledge gap regarding NSUN2’s immunoregulatory mechanisms inTNBC, and demonstrates significant clinical translational potential.  \nKeywords NSUN2, TNBC, Immunotherapy, Prognosis  \nAbbreviations  \nTNBC Triple-negative breast cancer m5C 5-methylcytosine  \nBC Breast cancer  \nER Estrogen receptor  \nPR Progesterone receptor  \nHER2 Human epidermal growth factor receptor 2  \nTME Tumor microenvironment  \nCAFs Cancer-associated fibroblasts  \nNK Natural killer  \nTAMS Tumor-associated macrophages  \nECM Extracellular matrix  \nICIs Immune checkpoint inhibitors  \nCTLA4 Cytotoxic T-lymphocyte-associated antigen 4 PD-1 Programmed death receptor-1  \nPD-L1 Programmed death receptor-ligand 1 ROS Reactive oxygen species  \nNSCLC Non-small cell lung cancer GO Gene ontology  \nDEGs Differentially expressed genes PCA Principal component analysis PPI Protein-protein interaction  \n1Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430079, Hubei, China. 2Department of Breast and Thyroid Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China. 3Breast cancer center, Tongji Medical College, Hubei Provincial Clinical Research Center for Breast Cancer, Hubei Cancer Hospital, Huazhong University of Science and Technology, National Key Clinical Specialty Construction Discipline, Wuhan Clinical Research Center for Breast Cancer, Wuhan 430079, Hubei, China. 􀀍 email:  \n[jwzhang68@whu.edu.cn](jwzhang68@whu.edu.cn); [Xiyq17@whu.edu.cn](Xiyq17@whu.edu.cn)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nGSEA Gene set enrichment analysis CCK-8 Cell counting kit-8  \nIM Immunomodulatory LAR Luminal androgen receptor MES Mesenchymal-like  \nBLIS Basal-like and immune suppressed  \nAs per the 2024 cancer report, breast cancer (BC) continues to hold the highest incidence rate among women globally, surpassing lung cancer in terms of fresh diagnoses1. TNBC characterized by the absence of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), comprises approximately 10 to 15% of all BC cases, highlighting its distinct molecular phenotype and clinical significance in oncological research2. TNBC exhibits a distinct tendency for early relapses and is more prone to distant metastasis, thereby conferring a less favorable prognosis compared to other BC subtypes.  \nTranscriptomic investigations have illuminated the existence of four distinct subtypes within TNBC: Imm","cbCaifu6IfxxbEzl","https://ap.wps.com/l/cbCaifu6IfxxbEzl","pdf",9060953,13,"English","# Introduction\n## TNBC immunotherapy challenges\n## NSUN2 and tumor progression\n## TNBC tumor microenvironment and immune infiltration","[{\"question\":\"Why is TNBC immunotherapy monotherapy still insufficient?\",\"answer\":\"Despite clinical remissions in many solid tumors, monotherapy efficacy in TNBC is not very satisfactory, indicating a need for improved strategies to enhance antitumor immunity.\"},{\"question\":\"How is NSUN2 related to TNBC prognosis and immune features?\",\"answer\":\"NSUN2 is highly expressed and higher levels correlate with poor prognosis in TNBC, and its expression positively associates with immune cell infiltration and immune checkpoint molecule expression.\"},{\"question\":\"How does NSUN2 affect TNBC cell behavior and treatment sensitivity?\",\"answer\":\"Depleting NSUN2 significantly inhibits TNBC cell proliferation and migration, and upregulated NSUN2 is linked to reduced sensitivity to many chemotherapy drugs while showing increased sensitivity to some molecular-targeted agents.\"}]","Oncogenic and immunological roles of NSUN2 in triple negative breast cancer | PDF",1790085088,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f794c3abb5b39be58a80d04e638a1b9d.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/496b47ff744c59e3d88b9e81a9a37a73.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d67d5d225e0723179a106dad9255515.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/115736b28afec48a9078da5ed387b51c.webp",980,1287]